Table 1 Baseline characteristics of the asthma study cohort

From: Ten-year longitudinal study of factors influencing nocturnal asthma symptoms among Asian patients in primary care

 

Overall (N=939)

No night symptom (N=385)

Night symptom (N=554)

Age

46.6 (23.0)

48.6 (23.1)

45.3 (22.8)

Duration of asthma

17.5 (16.8)

17.9 (16.7)

17.2 (16.9)

Weight

60.4 (20.8)

61.3 (19.8)

59.8 (21.4)

Height

152.0 (23.1)

152.6 (21.3)

151.7 (24.3)

Gender (Male)

418 (44.5)

166 (43.1)

252 (45.5)

Race

 Chinese

564 (60.1)

246 (63.9)

318 (57.4)

 Malay

132 (14.1)

68 (17.7)

122 (22.0)

 Indian

190 (20.2)

56 (14.6)

76 (13.7)

 Others

53 (5.6)

15 (3.9)

38 (6.9)

Rhinitis (Yes)

288 (30.7)

116 (30.1)

172 (31.1)

Conjunctivitis (Yes)

29 (3.1)

14 (3.6)

15 (2.7)

Eczema (Yes)

79 (8.4)

28 (7.3)

51 (59.0)

Cigarette smoking

 Current

64 (6.8)

20 (5.2)

44 (7.9)

 Ex-Smoker

104 (11.1)

40 (10.4)

64 (11.6)

 Never

771 (82.1)

325 (84.4)

446 (80.5)

Smoke as a trigger factor

 Yes

373 (39.8)

157 (40.8)

216 (39.1)

 No

549 (58.6)

222 (57.7)

327 (59.2)

 Unknown

15 (1.6)

6 (1.6)

9 (1.6)

Day off work

2/month

94 (11.2)

21 (6.0)

73 (14.9)

2/week

4 (0.5)

0 (0.0)

4 (0.8)

3/week

7 (0.8)

2 (0.6)

5 (1.0)

 None

735 (87.5)

327 (93.4)

408 (83.3)

Day off SOB

2/month

201 (21.5)

48 (12.6)

153 (27.6)

2/week

177 (18.9)

44 (11.5)

133 (24.0)

3/week

252 (26.9)

38 (10.0)

214 (38.6)

 None

306 (32.7)

252 (66.0)

54 (9.8)

Usual activities (number of days off work or school)

2/month

47 (5.3)

7 (1.9)

40 (7.7)

2/week

8 (0.9)

1 (0.3)

7 (1.3)

3/week

7 (0.8)

1 (0.3)

6 (1.2)

 None

829 (93.0)

360 (97.6)

469 (89.9)

Asthma severity classification a

 Intermittent

248 (26.5)

239 (62.4)

9 (1.6)

 Mild persistent

237 (25.3)

75 (19.6)

162 (29.3)

 Moderate persistent

302 (32.2)

65 (17.0)

237 (42.9)

 Severe persistent

149 (15.9)

4 (1.0)

145 (26.2)

  1. a Asthma severity classification is based on GINA guidelines in 2006. Results tabulated as mean (s.d.) or frequency (%).